Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis
- PMID: 10096557
Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis
Abstract
The effects of dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 on the apoptotic response of U937 monocytic leukemia cells to 1-beta-D-arabinofuranosylcytosine (ara-C) were examined. After a 6-h exposure to 1 microM ara-C, cells stably transfected with a p21WAF1/CIP1 antisense construct were significantly more sensitive to the induction of classic apoptotic morphology, DNA fragmentation, caspase-3 activation, poly(ADP-ribose) polymerase degradation, and underphosphorylation of the retinoblastoma protein (pRb) than their empty-vector counterparts. Enhanced susceptibility of antisense-expressing cells to ara-C was accompanied by a corresponding reduction in clonogenic and suspension culture growth. The increased sensitivity of these cells to ara-C-mediated lethality could not be attributed to cytokinetic perturbations, nor did ara-CTP formation or (ara-C)DNA incorporation differ significantly between the cell lines. Moreover, synchronization of p21 antisense-expressing cells in S-phase by aphidicolin block resulted in a further increase in ara-C-mediated apoptosis, suggesting enhanced drug sensitivity of the S-phase cell fraction. After exposure to ara-C, p21 antisense-expressing cells displayed a greater decline in mitochondrial membrane potential (deltapsi(m)) and generation of reactive oxygen species than their empty-vector counterparts, as well as early potentiation (e.g., within 2-4 h) of cytochrome c release into the cytosolic S-100 fraction. Lastly, ara-C-mediated increases in mitogen-activated protein kinase activity over basal levels were attenuated in p21 antisense-expressing cells. Collectively, these findings indicate that dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 increases the susceptibility of U937 human leukemia cells to ara-C-related lethality, and this phenomenon occurs as a relatively early event that is independent of cell cycle or pharmacodynamic factors and is associated with mitochondrial perturbations implicated in activation of the apoptotic protease cascade.
Similar articles
-
The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.Cancer Res. 2003 Jul 1;63(13):3637-45. Cancer Res. 2003. PMID: 12839953
-
The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.Cancer Res. 2001 Mar 15;61(6):2583-91. Cancer Res. 2001. PMID: 11289135
-
Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).Cell Growth Differ. 1996 May;7(5):603-13. Cell Growth Differ. 1996. PMID: 8732670
-
Regulation of p21waf1/cip1 expression by intracellular redox conditions.IUBMB Life. 2001 Jul;52(1-2):67-70. doi: 10.1080/15216540252774793. IUBMB Life. 2001. PMID: 11795596 Review.
-
p21Waf1/Cip1 as a therapeutic target in breast and other cancers.Cancer Cell. 2003 Dec;4(6):425-9. doi: 10.1016/s1535-6108(03)00308-8. Cancer Cell. 2003. PMID: 14706334 Review.
Cited by
-
JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells.Cancer Sci. 2010 Mar;101(3):774-81. doi: 10.1111/j.1349-7006.2009.01446.x. Epub 2009 Nov 18. Cancer Sci. 2010. PMID: 20028380 Free PMC article.
-
Porphyromonas gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via extracellular signal-regulated kinase-dependent expression of p21 Cip/WAF1.Infect Immun. 2001 Aug;69(8):4944-50. doi: 10.1128/IAI.69.8.4944-4950.2001. Infect Immun. 2001. PMID: 11447172 Free PMC article.
-
p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.Cell Cycle. 2015;14(22):3602-12. doi: 10.1080/15384101.2015.1100774. Cell Cycle. 2015. PMID: 26506264 Free PMC article.
-
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.Blood. 2007 May 15;109(10):4392-8. doi: 10.1182/blood-2006-03-012575. Epub 2007 Feb 6. Blood. 2007. PMID: 17284535 Free PMC article.
-
Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity.PLoS One. 2014 Jun 11;9(2):e98859. doi: 10.1371/journal.pone.0098859. eCollection 2014. PLoS One. 2014. PMID: 24918603 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials